PROVENGE.COM: Keyword Density Checker

Total words: 3471 | 2-word phrases: 901 | 3-word phrases: 1034 | 4-word phrases: 1093

PAGE INFO

Title	Try to keep the title under 60 characters (25 characters) PROVENGE® (sipuleucel-T)
Description	Try to keep the meta description between 50 - 160 characters (151 characters) What is metastatic castration-resistant prostate cancer? Metastatic castration-resistant prostate cancer (mCRPC) is a form of advanced prostate cancer.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (16 characters) It’s About

#	Keyword	Frequency	Density
1	advanced prostate cancer	6	0.58%
2	certain men with	4	0.39%
3	more about provenge	4	0.39%
4	learn more about	4	0.39%
5	of the body	4	0.39%
6	own immune cells	3	0.29%
7	prostate cancer cells	3	0.29%
8	your doctor about	3	0.29%
9	side effects of	3	0.29%
10	doctor about any	3	0.29%
11	tell your doctor	3	0.29%
12	have signs of	3	0.29%
13	the most common	3	0.29%
14	important safety information	3	0.29%
15	parts of the	2	0.19%
16	other parts of	2	0.19%
17	to other parts	2	0.19%
18	provide details pertaining	2	0.19%
19	also known as	2	0.19%
20	prostate cancer and	2	0.19%
21	please provide details	2	0.19%
22	of an arm	2	0.19%
23	common side effects	2	0.19%
24	most common side	2	0.19%
25	the prostate gland	2	0.19%
26	an arm or	2	0.19%
27	arm or leg	2	0.19%
28	details pertaining to	2	0.19%
29	metastatic castrationresistant prostate	2	0.19%
30	the right treatment	2	0.19%

#	Keyword	Frequency	Density
1	learn more about provenge	3	0.27%
2	provenge learn more about	2	0.18%
3	have signs of a	2	0.18%
4	and provide contact information	2	0.18%
5	provide contact information so	2	0.18%
6	metastatic castrationresistant prostate cancer?	2	0.18%
7	therapy also known as	2	0.18%
8	contact information so that	2	0.18%
9	your advanced prostate cancer	2	0.18%
10	about provenge learn more	2	0.18%
11	to other parts of	2	0.18%
12	an arm or leg	2	0.18%
13	the right treatment for	2	0.18%
14	information so that our	2	0.18%
15	castrationresistant prostate cancer mcrpc	2	0.18%
16	metastatic castrationresistant prostate cancer	2	0.18%
17	your doctor about any	2	0.18%
18	tell your doctor about	2	0.18%
19	may contact you with	2	0.18%
20	contact you with any	2	0.18%
21	right treatment for you	2	0.18%
22	you with any questions	2	0.18%
23	certain men with mcrpc	2	0.18%
24	side effects of provenge	2	0.18%
25	details pertaining to the	2	0.18%
26	of an arm or	2	0.18%
27	please provide details pertaining	2	0.18%
28	immunotherapy your provenge journey	2	0.18%
29	your provenge journey resources	2	0.18%
30	provide details pertaining to	2	0.18%
31	of advanced prostate cancer	2	0.18%
32	the most common side	2	0.18%
33	parts of the body	2	0.18%
34	most common side effects	2	0.18%
35	proven to extend life	2	0.18%
36	other parts of the	2	0.18%
37	concerns you or does	1	0.09%
38	are on narcotic treatment	1	0.09%
39	on narcotic treatment provenge	1	0.09%
40	narcotic treatment provenge has	1	0.09%

#	URL	Whois	Check
1	https://www.prostatecancerpatientprograms.com/	Whois	prostatecancerpatientprograms.com
2	http://www.fda.gov/medwatch	Whois	fda.gov